The influence of acute renal injury on arginine and methylarginines metabolism

References

• Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829–837
   PubMed Web of Science ®Google Scholar
• Caplin B, Leiper J. Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators? Arterioscler Thromb Vasc Biol. 2012;32(6):1343–1353
   PubMed Web of Science ®Google Scholar
• Nicholson TB, Chen T, Richard S. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol Res. 2009;60(6):466–474
   PubMed Web of Science ®Google Scholar
• Closs EI, Basha FZ, Habermeier A, Förstermann U. Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide. 1997;1(1):65–73
   PubMed Web of Science ®Google Scholar
• Dhanakoti SN, Brosnan JT, Herzberg GR, Brosnan ME. Renal arginine synthesis: studies in vitro and in vivo. Am J Physiol. 1990;259(3 Pt 1):E437–E442
   Google Scholar
• Wu G, Morris Jr SM. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336(Pt 1):1–17
   PubMed Web of Science ®Google Scholar
• Palm F, Onozato ML, Luo Z, Wilcox CS. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 2007;293(6):H3227–H3245
   PubMed Web of Science ®Google Scholar
• Achan V, Broadhead M, Malaki M, et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol. 2003;23(8):1455–1459
   PubMed Web of Science ®Google Scholar
• Yudkoff M, Nissim I, Pereira G, Segal S. Urinary excretion of dimethylarginines in premature infants. Biochem Med. 1984;32(2):242–251
   PubMedGoogle Scholar
• Schwedhelm E, Böger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7(5):275–285
   PubMed Web of Science ®Google Scholar
• Leiper J, Nandi M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discov. 2011;10(4):277–291
   PubMed Web of Science ®Google Scholar
• Brunini TM, Roberts NB, Yaqoob MM, Ellory JC, Mann GE, Mendes Ribeiro AC. Activation of l-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients. Clin Exp Pharmacol Physiol. 2006;33(1–2):114–118
   PubMed Web of Science ®Google Scholar
• Chander V, Chopra K. Molsidomine, a nitric oxide donor and l-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochim Biophys Acta. 2005;1723(1–3):208–214
   PubMed Web of Science ®Google Scholar
• Dai C, Kiss LP, Liu Y. Animal models of kidney diseases. In: Conn PM, ed. Sourcebook of Models for Biomedical Research. New Jersey: Humana Press; 2008:657–665
   Google Scholar
• Teerlink T. HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids. J Chromatogr B. 2007;851(1–2):21–29
   PubMed Web of Science ®Google Scholar
• Nonaka S, Tsunoda M, Aoyama C, Funatsu T. Determination of NG,NG-dimethyl-l-arginine in rat plasma and dimethylarginine dimethylaminohydrolase activity in rat kidney using a monolithic silica column. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;843(2):170–174
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
   PubMed Web of Science ®Google Scholar
• Navarro-Gonzálvez JA, García-Benayas C, Arenas J. Semiautomated measurement of nitrate in biological fluids. Clin Chem. 1998;44(3):679–681
   PubMed Web of Science ®Google Scholar
• Schramm L, La M, Heidbreder E, et al. l-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int. 2002;61(4):1423–1432
   PubMed Web of Science ®Google Scholar
• Prins HA, Nijveldt RJ, Gasselt DV, et al. The flux of arginine after ischemia--reperfusion in the rat kidney. Kidney Int. 2002;62(1):86–93
   PubMed Web of Science ®Google Scholar
• Perez GO, Rietberg B, Owens B, Schiff ER. Effect of acute uremia on arginine metabolism and urea and guanidino acid production by perfused rat liver. Pflugers Arch. 1977;372(3):275–278
   PubMed Web of Science ®Google Scholar
• Elliott DA. Nutritional considerations for the dialytic patient. Vet Clin North Am Small Anim Pract. 2011;41(1):239–250
   PubMed Web of Science ®Google Scholar
• Leiper JM, Santa Maria J, Chubb A, et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J. 1999;343(Pt 1):209–214
   PubMed Web of Science ®Google Scholar
• Sydow K, Münzel T. ADMA and oxidative stress. Atheroscler Suppl. 2003;4(4):41–51
   PubMed Web of Science ®Google Scholar
• Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62–72
   PubMed Web of Science ®Google Scholar
• Onozato ML, Tojo A, Leiper J, Fujita T, Palm F, Wilcox CS. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers. Diabetes. 2008;57(1):172–180
   PubMed Web of Science ®Google Scholar
• Matsuguma K, Ueda S, Yamagishi S, et al. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol. 2006;17(8):2176–2183
   PubMed Web of Science ®Google Scholar
• Siroen MP, Teerlink T, Nijveldt RJ, Prins HA, Richir MC, van Leeuwen PA. The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr. 2006;26:203–228
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function – a meta-analysis. Nephrol Dial Transplant. 2006;21(9):2446–2451
   PubMed Web of Science ®Google Scholar
• Carello KA, Whitesall SE, Lloyd MC, Billecke SS, D'Alecy LG. Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol. 2006;290(1):209–216
   Web of Science ®Google Scholar
• Kielstein JT, Veldink H, Martens-Lobenhoffer J, et al. SDMA is an early marker of change in GFR after living-related kidney donation. Nephrol Dial Transplant. 2011;26(1):324–328
   PubMed Web of Science ®Google Scholar
• Mitch WE, May RC, Maroni BJ, Druml W. Protein and amino acid metabolism in uremia: influence of metabolic acidosis. Kidney Int Suppl. 1989;27:S205–S207
   Google Scholar
• Al Banchaabouchi M, Marescau B, Possemiers I, D'Hooge R, Levillain O, De Deyn PP. NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency. Pflugers Arch. 2000;439(5):524–531
   PubMed Web of Science ®Google Scholar
• Yeung KK, Richir M, Hanrath P, et al. Infrarenal aortic-clamping after renal ischemia aggravates acute renal failure. Eur J Clin Invest. 2011;41(6):605–615
   PubMed Web of Science ®Google Scholar
• Richir MC, van Lambalgen AA, Teerlink T, et al. Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model. Crit Care Med. 2009;37(6):2010–2017
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003;14(8):2199–2210
   PubMed Web of Science ®Google Scholar
• Valdivielso JM, Lopez-Novoa JM, Eleno N, Perez Barriocanal F. Role of glomerular nitric oxide in glycerol-induced acute renal failure. Can J Physiol Pharmacol. 2000;78(6):476–482
   PubMed Web of Science ®Google Scholar
• Chander V, Chopra K. Protective effect of resveratrol, a polyphenolic phytoalexin on glycerol-induced acute renal failure in rat kidney. Ren Fail. 2006;28(2):161–169
   PubMed Web of Science ®Google Scholar